Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Intermittent Periods Based on ctDNA-MRD Status in Advanced HER2-Positive Breast Cancer: A Non-Interventional Exploratory Study

NCT07132502 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT07132502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07132502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Intermittent Periods Based on ctDNA-MRD Status in Advanced HER2-Positive Breast Cancer: A Non-Interventional Exploratory Study
Lead sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Observational
Overall status
Not yet recruiting
Start date
August 25, 2025
Completion date
July 15, 2027
Enrollment
24 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer